Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis

Clinical Rheumatology

Volumn 35, Issue 10, 2016, Pages 2437-2448

  Chen, Junzhe ^a   Tang, Ying ^a   Zhu, Mingsheng ^a   Xu, Anping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cardiac structure and function; Echocardiography; Systemic lupus erythematosus; Systemic review and meta analysis

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART ATRIUM HYPERTROPHY; HEART DISEASE; HEART LEFT VENTRICLE MASS; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; META ANALYSIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PUBLISHING; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE; COMPLICATION; DIAGNOSTIC IMAGING; FEMALE; HEART; HEART LEFT VENTRICLE FUNCTION; MALE; PATHOPHYSIOLOGY;

ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PERICARDIAL EFFUSION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84981287977     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-016-3373-z     Document Type: Article

References (50)

1. Mok CC (2011) Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 20:767–771
2. Urowitz MB, Bookman AA, Koehler BE, et al. (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225
3. Doria A, Iaccarino L, Ghirardello A, et al. (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700–706
4. Gustafsson JT, Simard JF, Gunnarsson I, et al. (2012) Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther 14:46
5. Chen SC, Chang JM, Liu WC, et al. (2012) Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Nephrol Dial Transplant 27:1064–1070
6. Doria A, Iaccarino L, Sarzi-Puttini P, et al. (2005) Cardiac involvement in systemic lupus erythematosus. Lupus 14:683–686
7. Wislowska M, Deren D, Kochmanski M, et al. (2009) Systolic and diastolic heart function in SLE patients. Rheumatol Int 29:1469–1476
8. Gin PL, Wang WC, Yang SH, et al. (2006) Right heart function in systemic lupus erythematosus: insights from myocardial Doppler tissue imaging. J Am Soc Echocardiogr 19:441–449
9. Roman MJ, Salmon JE, Sobel R, et al. (2001) Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am J Cardiol 87:663–666
10. Shang Q, Yip GW, Tam LS, et al. (2012) SLICC/ACR damage index independently associated with left ventricular diastolic dysfunction in patients with systemic lupus erythematosus. Lupus 21:1057–1062
11. Gabrielli F, Alcini E, Prima MA, et al. (1996) Cardiac involvement in connective tissue diseases and primary antiphospholipid syndrome: echocardiographic assessment and correlation with antiphospholipid antibodies. Acta Cardiol 51:425–439
12. Leszczynski P, Straburzynska-Migaj E, Korczowska I, et al. (2003) Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies. Clin Rheumatol 22:405–408
13. Jensen-Urstad K, Svenungsson E, de Faire U, et al. (2002) Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease. Lupus 11:744–752
14. Roldan CA, Shively BK, Crawford MH (1996) An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335:1424–1430
15. Plazak W, Kopec G, Tomkiewicz-Pajak L, et al. (2011) Heart structure and function in patients with generalized autoimmune diseases: echocardiography with tissue Doppler study. Acta Cardiol 66:159–165
16. Gabrielli F, Alcini E, Di Prima MA, et al. (1995) Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 51:117–126
17. Roldan CA, Qualls CR, Sopko KS, et al. (2008) Transthoracic versus transesophageal echocardiography for detection of Libman-sacks endocarditis: a randomized controlled study. J Rheumatol 35:224–229
18. Paradiso M, Gabrielli F, Masala C, et al. (2001) Evaluation of myocardial involvement in systemic lupus erythematosus by signal-averaged electrocardiography and echocardiography. Acta Cardiol 56:381–386
19. Teixeira AC, Bonfa E, Herskowictz N, et al. (2010) Early detection of global and regional left ventricular diastolic dysfunction in systemic lupus erythematosus: the role of the echocardiography. Rev Bras Rheumatol 50:16–30
20. Amoroso A, Cacciapaglia F, De Castro S, et al. (2006) The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement. Clin Exp Rheumatol 24:287–294
21. Toumanidis ST, Papamichael CM, Antoniades LG, et al. (1995) Cardiac involvement in collagen diseases. Eur Heart J 16:257–262
22. Falcao CA, Alves IC, Chahade WH, et al. (2002) Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus. Arq Bras Cardiol 79:285–291
23. Wranicz JK, Cygankiewicz I, Zielinska M, et al. (2001) Non-invasive cardiac evaluation in patients with systemic lupus erythematosus. J Med 32:195–206
24. Lee SW, Park MC, Park YB, et al. (2008) E/E’ ratio is more sensitive than E/a ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus. Lupus 17:195–201
25. Perez-Villa F, Font J, Azqueta M, et al. (2005) Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow up study. Arthritis Rheum 53:460–467
26. Kalke S, Balakrishanan C, Mangat G, et al. (1998) Echocardiography in systemic lupus erythematosus. Lupus 7:540–544
27. Cervera R, Font J, Pare C, et al. (1992) Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 51:156–159
28. Yu XH, Li YN (2011) Echocardiographic abnormalities in a cohort of Chinese patients with systemic lupus erythematosus—a retrospective analysis of eighty-five cases. J Clin Ultrasound 39:519–526
29. Pocock SJ, Collier TJ, Dandreo KJ, et al. (2004) Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 329:883
30. Stroup DF, Berlin JA, Morton SC, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012
31. Phillips B, Ball C, Sackett D (2012) Levels of evidence and grades of recommendation. Oxford Centre for Evidence-based Medicine Web site. http://www.cebm.net/index.aspx?o=10
32. Wells GA, Shea B, O’Connell D et al (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute Web site. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
33. Higgins JP, Thompson SG (2008) Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration, New York
34. Maksimovic R, Seferovic PM, Ristic AD, et al. (2006) Cardiac imaging in rheumatic diseases. Rheumatology (Oxford) 45(Suppl 4):v26–v31
35. Sugiura T, Kumon Y, Kataoka H, et al. (2009) Asymptomatic pericardial effusion in patients with systemic lupus erythematosus. Lupus 18:128–132
36. Omdal R, Lunde P, Rasmussen K, et al. (2001) Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosus. Scand J Rheumatol 30:275–281
37. Bidani AK, Roberts JL, Schwartz MM, et al. (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69:849–858
38. Crozier IG, Li E, Milne MJ, et al. (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65:1145–1148
39. Pieretti J, Roman MJ, Devereux RB, et al. (2007) Systemic lupus erythematosus predicts increased left ventricular mass. Circulation 116:419–426
40. Yip GW, Shang Q, Tam LS, et al. (2009) Disease chronicity and activity predict subclinical left ventricular systolic dysfunction in patients with systemic lupus erythematosus. Heart 95:980–987
41. Paran D, Caspi D, Levartovsky D, et al. (2007) Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 66:506–510
42. Tincani A, Rebaioli CB, Taglietti M, et al. (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45(Suppl 4):v8–v13
43. Mavrogeni S, Bratis K, Kolovou G (2012) Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging. Lupus 21:821–829
44. Ishimori ML, Martin R, Berman DS, et al. (2011) Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging 4:27–33
45. Mavrogeni S, Dimitroulas T, Kitas GD (2012) Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 12:305–312
46. Mavrogeni S, Vassilopoulos D (2011) Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases? Semin Arthritis Rheum 41:488–496
47. Deetjen AG, Conradi G, Mollmann S, et al. (2007) Diagnostic value of the 16-detector row multislice spiral computed tomography for the detection of coronary artery stenosis in comparison to invasive coronary angiography. Clin Cardiol 30:118–123
48. George SM, Kalantarinia K (2011) The role of imaging in the management of cardiorenal syndrome. Int J Nephrol 2011:245241
49. Hasebroock KM, Serkova NJ (2009) Toxicity of MRI and CT contrast agents. Expert Opin Drug Metab Toxicol 5:403–416
50. Pennell DJ, Sechtem UP, Higgins CB, et al. (2004) Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. J Cardiovasc Magn Reson 6:727–765